MARC Record from Library of Congress

LEADER: 01704cam a2200349 i 4500
001 2013043146
003 DLC
005 20150130083400.0
008 131029t20142014ne a b 001 0 eng
010 $a 2013043146
020 $a9780123820303 (alk. paper)
020 $a0123820308 (alk. paper)
040 $aDLC$beng$cDLC$erda$dDLC
042 $apcc
050 00 $aRS403$b.S55 2014
082 00 $a615.1/9$223
100 1 $aSilverman, Richard B.,$eauthor.
245 14 $aThe organic chemistry of drug design and drug action.
250 $aThird edition /$bRichard B. Silverman, Northwestern University, Department of Chemistry, Department of Molecular Biosciences, Chemistry of Life Processes Institute, Center for Molecular Innovation and Drug Discovery, Evanston, Illinois, USA, Mark W. Holladay, Ambit Biosciences Corporation, Departments of Drug Discovery and Medicinal Chemistry, San Diego, California, USA.
264 1 $aAmsterdam ;$aBoston :$bElsevier/AP, Academic Press, is an imprint of Elsevier,$c[2014]
264 4 $c©2014
300 $axviii, 517 pages :$billustrations (some color) ;$c29 cm
336 $atext$2rdacontent
337 $aunmediated$2rdamedia
338 $avolume$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems.
650 0 $aPharmaceutical chemistry.
650 0 $aBioorganic chemistry.
650 0 $aMolecular pharmacology.
650 0 $aDrugs$xDesign.
700 1 $aHolladay, Mark W.,$eauthor.